Autoimmune cytopenias in chronic lymphocytic leukemia

被引:1
|
作者
Haider, M. Shabih [1 ]
Khan, Saleem Ahmed [1 ]
Nasiruddin [1 ]
Shahid, Samra [1 ]
机构
[1] Army Med Coll, Dept Pathol, Haematol Sect, Rawalpindi, Pakistan
关键词
Autoimmune granulocytopenia; Autoimmune hemolytic anaemia; Chronic lymphocytic leukemia; Immune thrombocytopenic purpura; Pure red cell aplasia; DIAGNOSIS; GUIDELINES;
D O I
10.12669/pjms.35.5.369
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the frequency of autoimmune cytopenias in chronic lymphocytic leukemia. Methods: This cross sectional study was carried out at Department of Hematology, Army Medical College Rawalpindi, in collaboration with Military Hospital Rawalpindi and Armed Forces institute of Pathology Rawalpindi from 1st January 2018 to 1st October 2018. Sample size of 64 was calculated using WHO calculator. Age and gender of patients was noted. Frequency of autoimmune hemolytic anaemia, immune thrombocytopenic purpura, pure red cell aplasia and autoimmune agranulocytosis were determined in diagnosed patients of chronic lymphocytic leukemia by various laboratory tests in our study population. Results: A total of 64 patients were included in the study, 53 (82.8%) were males and 11(17.2%) were females. Mean age of patients was 65 years. Autoimmune hemolytic anaemia was observed in 5/64 (7.8%) of patients. Immune thrombocytopenic purpura was seen in 2/64 (3.1%) patients. Autoimmune granuloytopenia and pure red cell aplasia were not seen in any patient. Conclusion: Autoimmune hemolytic anaemia and immune thrombocytopenic purpura are the most common causes of immune cytopenias in patients of CLL. Immune cytopenias should always be identified by laboratory tests as their management differs from other cytopenias which occur due to various other causes.
引用
收藏
页码:1334 / 1338
页数:5
相关论文
共 50 条
  • [31] Pre-Existing and Treatment-Emergent Autoimmune Cytopenias in Patients with Chronic Lymphocytic Leukemia Treated with Targeted Drugs
    Vitale, Candida
    Salvetti, Chiara
    Griggio, Valentina
    Scamuffa, Maria Cristina
    Zamprogna, Giulia
    Visentin, Andrea
    Cassin, Ramona
    Laurenti, Luca
    Murru, Roberta
    Rivela, Paolo
    Marchetti, Monia
    Gentile, Massimo
    Pennese, Elsa
    Reda, Gianluigi
    Trentin, Livio
    Tedeschi, Alessandra
    Mauro, Francesca Romana
    Foa, Robin
    Boccadoro, Mario
    Coscia, Marta
    BLOOD, 2019, 134
  • [32] Regulatory T-cells in B-cell chronic lymphocytic leukemia: their role in disease progression and autoimmune cytopenias
    Lad, Deepesh P.
    Varma, Subhash
    Varma, Neelam
    Sachdeva, Man Updesh Singh
    Bose, Parveen
    Malhotra, Pankaj
    LEUKEMIA & LYMPHOMA, 2013, 54 (05) : 1012 - 1019
  • [33] RETRACTED: Rituximab-cyclophosphamide-dexamethasone combination in management of autoimmune cytopenias associated with chronic lymphocytic leukemia (Retracted Article)
    Michallet, Anne-Sophie
    Rossignol, Julien
    Cazin, Bruno
    Ysebaert, Loic
    LEUKEMIA & LYMPHOMA, 2011, 52 (07) : 1401 - 1403
  • [34] Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias
    Eugene Nikitin
    Maria Kislova
    Dmitry Morozov
    Vera Belyakova
    Anna Suvorova
    Julia Sveshnikova
    Galina Vyscub
    Irina Matveeva
    Maria Shirokova
    Anna Shipaeva
    Tatyana Klitochenko
    Polina Makarovskaya
    Elena Dmitrieva
    Bella Biderman
    Andrei Sudarikov
    Tatyana Obukhova
    Olga Samoilova
    Kamil Kaplanov
    Tatyana Konstantinova
    Olga Mayorova
    Irina Poddubnaya
    Vadim Ptushkin
    Leukemia, 2023, 37 : 1464 - 1473
  • [35] INTENSIVE LEUKAPHERESIS IN THE MANAGEMENT OF CYTOPENIAS IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) AND LYMPHOCYTIC LYMPHOMA
    COOPER, IA
    DING, JC
    ADAMS, PB
    QUINN, MA
    BRETTELL, M
    AMERICAN JOURNAL OF HEMATOLOGY, 1979, 6 (04) : 387 - 398
  • [36] A matter of debate in chronic lymphocytic leukemia: is the occurrence of autoimmune disorders an indicator of chronic lymphocytic leukemia therapy?
    Strati, Paolo
    Caligaris-Cappio, Federico
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (05) : 455 - 460
  • [37] Ibrutinib in patients with autoimmune cytopenias and previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) from the phase 3 RESONATETM study
    Montillo, Marco
    O'Brien, Susan
    Tedeschi, Alessandra
    Byrd, John
    Dearden, Claire
    Gill, Devinder
    Brown, Jennifer
    Barrientos, Jacqueline
    Mulligan, Stephen
    Furman, Richard
    Cymbalista, Florence
    Plascencia, Clara
    Chang, Stephen
    Hsu, Emily
    James, Danelle
    Hillmen, Peter
    LEUKEMIA & LYMPHOMA, 2015, 56 : 150 - 151
  • [38] Management of autoimmune cytopenia complicating chronic lymphocytic leukemia
    Zent, Clive S.
    Shanafelt, Tait
    LEUKEMIA & LYMPHOMA, 2009, 50 (06) : 863 - 864
  • [39] Autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia
    Al Hadidi, Samer
    Udden, Mark
    CLINICAL CASE REPORTS, 2020, 8 (06): : 1112 - 1113
  • [40] Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients
    Tijanic, I
    Bakic, M
    Tasic, J
    Macukanovic-Golubovic, L
    Vukicevic, T
    Milenovic, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 316 - 316